Paper313402
An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
Zerwekh JE and 3 others. J Clin Endocrinol Metab, 1979. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. Papers, record 313402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/313402
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ergocalciferols | Major topic |
| Hydroxycholecalciferols | Major topic |
| Osteomalacia | Major topic |
| Adult | |
| Calcium | |
| Female | |
| Humans | |
| Intestinal Absorption | |
| Phosphates |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15128933 | Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15128933 | PubMed |
| 6976436 | Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981. | J R Coll Physicians Lond | 1981 | https://conductscience.org/library/papers/6976436 | PubMed |
| 6775776 | Tumoral calcinosis: evidence for concurrent defects in renal tubular phosphorus transport and in 1 alpha,25-dihydroxycholecalciferol synthesis. | Calcif Tissue Int | 1980 | https://conductscience.org/library/papers/6775776 | PubMed |
| 6770981 | Vitamin D-dependent rickets type II. | Calcif Tissue Int | 1980 | https://conductscience.org/library/papers/6770981 | PubMed |
| 6332830 | Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6332830 | PubMed |
| 6313754 | Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6313754 | PubMed |
| 6296200 | Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6296200 | PubMed |
| 6279228 | Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6279228 | PubMed |
| 3937578 | Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis. | Calcif Tissue Int | 1985 | https://conductscience.org/library/papers/3937578 | PubMed |
| 3872316 | Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts. | J Clin Invest | 1985 | https://conductscience.org/library/papers/3872316 | PubMed |
| 3489007 | Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3489007 | PubMed |
| 3089562 | Bone in the marmoset: a resemblance to vitamin D-dependent rickets, type II. | Calcif Tissue Int | 1986 | https://conductscience.org/library/papers/3089562 | PubMed |
| 3024987 | Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia. | Eur J Pediatr | 1986 | https://conductscience.org/library/papers/3024987 | PubMed |
| 3009551 | Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3009551 | PubMed |
| 2991334 | Vitamin D-endocrine system. | J Clin Invest | 1985 | https://conductscience.org/library/papers/2991334 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP2R1 | 120227 | PubTator's text mining | https://conductscience.org/library/genes/120227 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/313402
GET https://conductscience.org/api/papers/v1/313402/authors